UK Renal Registry Chooses InterSystems HealthShare for Chronic Kidney Disease Monitoring and Reporting in Britain

InterSystemsInterSystems, a global leader in software for connected care, today announced that the UK Renal Registry has chosen InterSystems HealthShare® as its new national health informatics platform, gathering data from 84 adult and paediatric renal units, plus satellite haemodialysis units, on over 56,000 patients suffering from stage 5 chronic kidney disease (CKD). HealthShare will allow the Renal Registry to collect near real-time information on patients, helping to improve standards of care across the country through greater data accuracy and more regular, consistent reporting on renal unit performance.

The UK Renal Registry consolidates the collection and analysis of standardised data relating to the incidence, clinical management, and outcome of renal disease to ensure high levels of care at NHS renal units, measured against the standards set by the UK Renal Association. Previously, this information was gathered by disparate IT systems and fed into the UK Renal Registry on a quarterly basis, where it was manually validated, analysed and published in the Registry’s annual report. However, with the implementation of HealthShare, the UK Renal Registry will now:

  • Have a daily data feed
  • Reduce the need for human validation and achieve greater accuracy and consistency of reporting
  • Be able to produce detailed quarterly reports, providing units with greater clarity on their performance
  • More easily track and maintain individual patient records.

Using HealthShare, the Registry will make it easier for clinicians to monitor patient treatment, enabling them to instantly access a patient’s renal data, even if they do not have an existing renal record at that particular treatment centre. This is particularly important for patients moving between transplant and dialysis units and those on holiday, as their treatment can be more accurately tracked and reported, reducing the risk of errors and unnecessary duplicate tests.

Ron Cullen, Director at the UK Renal Registry, said, "The UK Renal Registry is a charitable organisation funded by the NHS and tasked with understanding the care chronic kidney disease patients receive. InterSystems' international reputation and experience with strategic interoperability in healthcare means it is the ideal partner to update our informatics systems nationally and ready our service for the future.

"InterSystems HealthShare will allow us to gather more data, more accurately. The platform will also help us achieve our ambition to expand the registry to over 1 million CKD sufferers, which will include not just stage 5 patients, but also stages 2 to 4. We also hope to use the platform to build new tools for clinicians and patients, such as a medicine reconciliation function, which will improve patient care as well as providing cost savings for the NHS," Cullen added.

Steve Garrington, Vice President, International, InterSystems, commented: "We are delighted that the UK Renal Registry has chosen the InterSystems HealthShare health informatics platform to help clinicians capture, share, understand, and act upon their data in a more timely manner. The Registry provides an invaluable service, and HealthShare will support its goal to improve the quality of care for renal patients in Britain."

The Registry chose HealthShare because of its scalability, the time and cost savings from improved data accuracy, and its ability to provide near real-time data. The implementation is being completed by UK Renal Registry staff.

Related news articles:

About InterSystems
InterSystems develops advanced software technologies that enable breakthroughs. Through its data management, integration, and analytics technologies, InterSystems is dedicated to helping clients and partners succeed by deriving meaning and value from data. InterSystems is the global leader in software for connected healthcare, and industries with extreme performance requirements, including high-volume financial trading, energy, and government, rely on InterSystems software. Founded in 1978, privately held InterSystems is headquartered in Cambridge, Massachusetts (USA), with offices worldwide serving clients and partners in more than 100 countries.

About The Renal Registry UK
The Renal Registry is non-profit making and as part of the Renal Association is registered as a charitable activity by the Charity Commission.

The Registry was established by the Renal Association with support from the Department of Health, the British Association of Paediatric Nephrologists, and the British Transplant Society as a resource for the development of patient care in renal disease. It provides a focus for the collection and analysis of standardised data relating to the incidence, clinical management and outcome of renal disease. The UK Renal Registry monitors indicators of the quality as well as quantity of care, with the aim of improving the standard of care.

The Registry provides data for participating renal units, NHS Trusts, commissioning authorities, regional offices, patient groups and researchers. The development of the Registry is open to influence by all interested parties including clinicians, Trusts, commissioning authorities, patient organisations and researchers.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...